RANK Expression and Osteoclastogenesis in Human Monocytes in Peripheral Blood from Rheumatoid Arthritis Patients

Rheumatoid arthritis (RA) appears as inflammation of synovial tissue and joint destruction. Receptor activator of NF-κB (RANK) is a member of the TNF receptor superfamily and a receptor for the RANK ligand (RANKL). In this study, we examined the expression of RANKhigh and CCR6 on CD14+ monocytes from patients with RA and healthy volunteers. Peripheral blood samples were obtained from both the RA patients and the healthy volunteers. Osteoclastogenesis from monocytes was induced by RANKL and M-CSF in vitro. To study the expression of RANKhigh and CCR6 on CD14+ monocytes, two-color flow cytometry was performed. Levels of expression of RANK on monocytes were significantly correlated with the level of osteoclastogenesis in the healthy volunteers. The expression of RANKhigh on CD14+ monocyte in RA patients without treatment was elevated and that in those receiving treatment was decreased. In addition, the high-level expression of RANK on CD14+ monocytes was correlated with the high-level expression of CCR6 in healthy volunteers. Monocytes expressing both RANK and CCR6 differentiate into osteoclasts. The expression of CD14+RANKhigh in untreated RA patients was elevated. RANK and CCR6 expressed on monocytes may be novel targets for the regulation of bone resorption in RA and osteoporosis.

[1]  Sakae Tanaka.  Regulation of bone destruction in rheumatoid arthritis through RANKL-RANK pathways. , 2013, World journal of orthopedics.

[2]  Yusuke Nakamura,et al.  A regulatory variant in CCR6 is associated with rheumatoid arthritis susceptibility , 2010, Nature Genetics.

[3]  H. Yamanaka,et al.  Human osteoclastogenic T cells and human osteoclastology. , 2009, Arthritis and rheumatism.

[4]  Takashi Nakamura,et al.  CCL20 produced in the cytokine network of rheumatoid arthritis recruits CCR6+ mononuclear cells and enhances the production of IL-6. , 2009, Cytokine.

[5]  A. Cope,et al.  Treg cells suppress osteoclast formation: a new link between the immune system and bone. , 2007, Arthritis and rheumatism.

[6]  Hiromu Ito,et al.  Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model , 2007, The Journal of experimental medicine.

[7]  C. Manferdini,et al.  CCL20 chemokine induces both osteoblast proliferation and osteoclast differentiation: Increased levels of CCL20 are expressed in subchondral bone tissue of rheumatoid arthritis patients , 2007, Journal of cellular physiology.

[8]  A. Evdokiou,et al.  RANK Expression as a Cell Surface Marker of Human Osteoclast Precursors in Peripheral Blood, Bone Marrow, and Giant Cell Tumors of Bone , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[9]  N. Kamatani,et al.  IFN‐γ‐producing human T cells directly induce osteoclastogenesis from human monocytes via the expression of RANKL , 2005, European journal of immunology.

[10]  T. Martin,et al.  IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. , 1999, The Journal of clinical investigation.

[11]  L. Avioli,et al.  Ovarian steroid treatment blocks a postmenopausal increase in blood monocyte interleukin 1 release. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[12]  M. Liang,et al.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.

[13]  S. Teitelbaum,et al.  Spontaneous release of interleukin 1 from human blood monocytes reflects bone formation in idiopathic osteoporosis. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[14]  H. Takayanagi.  SnapShot: Osteoimmunology. , 2015, Cell Metabolism.